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ABSTRACT 
 
  
 
This work describes a novel use for the polymeric film, poly(o-aminophenol) (PAP) that was made respon- sive to a specific protein. This was achieved 
through templated electropolymerization of aminophenol (AP) in the presence of protein. The procedure involved adsorbing prot ein on the electrode 
surface and thereafter electroploymerizing the aminophenol. Proteins embedded at the outer surface of the polymeric film were digested by proteinase K 
and then washed away thereby creating vacant sites. The capacity of the template film to specifically rebind protein was  tested with myoglobin (Myo), a 
cardiac biomarker for ischemia. The films acted as biomimetic artificial antibodies and were produced on a gold (Au) screen printed electrode (SPE), as a 
step towards disposable sensors to enable point-of-care  applications. 
Raman spectroscopy was used to follow the surface modification of the Au-SPE. The ability of the mate- rial to rebind Myo was measured by 
electrochemical techniques, namely electrochemical impedance spectroscopy (EIS) and square wave voltammetry (SWV). The devices displayed linear 
responses to Myo in EIS and SWV assays down to 4.0 and 3.5 µg/mL, respectively, with detection limits of 1.5 and 
0.8 µg/mL. Good selectivity was observed in the presence of troponin T (TnT) and creatine kinase (CKMB) in SWV assays, and accurate results were 
obtained in applications to spiked serum. The sensor described in this work is a potential tool for screening Myo in point-of-care due to the simplicity of 
fabrication, disposability, short time response, low cost, good sensitivity and selectivity. 
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1. Introduction 
 
Cardiovascular diseases affect the heart and surrounding blood 
vessels, and manifest many forms, such as high blood pressure, 
coronary artery disease, valvular heart disease, stroke, or rheumatic 
heart disease. These are the largest single cause of death in the    
EU, accounting 42% deaths in 2010 [1]. Following cardiovascular 
biomarkers is a key tool in the fight against cardiovascular dis- 
eases, aimed at preserving the patient’s life and delivering effective 
therapies and a successful prognosis for the disease    [2–4]. 
Acute events in cardiovascular diseases are here of special 
concern, and have been successfully diagnosed by monitoring sev- 
eral well-known biomarkers, such as Creatine kinase isoenzyme 
(CKMB) [5,6], cardiac troponin I or T (Tn) [5,7], brain natriuretic 
 
 
peptide (BNP) [8] and Myoglobin [3,4]. Timely measurements of 
these biomarkers demands access to low-cost devices, providing 
rapid responses and capable of operating in point-of-care. 
Current techniques used to determine cardiovascular biomark- 
ers rely on immune/antigen reactions, in a wide range of 
approaches that include counter-immunoelectrophoresis, latex 
agglutination quantitative microcomplement fixation assay, and 
radioimmunoassay [4,9,10]. These rely on the great specificity of 
an antibody towards its antigen, a condition that ensures an easy 
handling of complex blood samples. However, most of these are 
not portable and require procedures that can only be made in a 
clinical laboratory, which is clearly inappropriate for point-of-care 
applications. The overall procedure may also take much longer 
than desired in acute events, reaching 2 h. Alternative methods to 
immunoassays use highly sophisticated chromatographic or elec- 
trophoretic procedures [11–13], which are expensive and again 
unsuitable to carry out analysis in point-of care. 
It is therefore important to look for other ways of monitor- 
ing biomarkers in cardiovascular diseases, bringing significant 
long-term economic, health and social benefits to our society. 
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(Bio)Sensors could be an alternative, because they allow rapid 
diagnosis in point-of-care, providing reduced response times and 
leading to better outcomes of the disease, most especially in acute 
events [2,14]. The receptor element is at the core of the device selec- 
tivity, an essential condition for detecting proteins that circulate in 
the blood at quite low concentrations. 
Natural receptors namely antibodies, nucleic acids, and 
enzymes, have been widely used in biosensors for targeting cardiac 
biomarkers, leading to electrochemical, optical, mass or magnetic 
changes [2]. In general, natural receptors offer high selectivity 
towards a target analyte, but show decreased chemical stability, 
and are rather expensive. Thus, biomimetic materials have been 
sought for many years as synthetic receptors. 
Molecularly imprinted polymers (MIPs) are among these 
biomimetic materials and act as plastic antibodies in chemical 
sensors. In general, MIPs are obtained by 3-D (bulk) or 2-D (sur- 
face) imprinting of the complete molecule or parts of it (epitopes)  
in a rigid polymeric matrix of either organic (vinyl functional 
derivatives) or inorganic (silica derivatives) materials. The template 
molecule is subsequently removed and the resulting polymeric 
network  keeps  the  ability  to  rebind  the  template  because  of  
the steric and electronic characteristics of the resulting cavities 
[15,16]. Molecular imprinting technology creates materials whose 
binding specificity is similar to that of antibody–antigen interac- 
tions [17,18]. These materials offer unique opportunities in terms   
of reversible inclusion of a bioanalyte [19], mechanical/chemical 
stability, low price potentially and compatibility with mass manu- 
factures   [18,20–22]. 
While the imprinting of small molecules has been successfully 
achieved, protein imprinting is still a challenge [23]. The restricted 
protein mobility within the polymeric network and the weak effi- 
ciency/reversibility of binding are major technical hitches. 2-D 
imprinting seems more reliable in this case, because the binding 
sites are exposed at the surface allowing easy access/removal of the 
proteins to/from these. However, in surface imprinting the number 
of binding sites is rather limited compared to bulk, by the small 
area available for (re)binding. Thus, a suitable MIP design must be 
selected. 
Few strategies of protein surface imprinting in cardiac 
biomarker sensing context have been employed so far [23–29], 
involving surface imprinting procedures on gold [24,28–30], sil- 
ica [25,26], or carbon [27], while employing different approaches 
for assembling the polymeric network. Among these, electropoly- 
merization seems to be the simplest approach towards protein 
imprinting that seems to have been developed first by Panasyuk 
et al. for a small target analyte [31], and applied later to proteins by 
Cai et al. [32]. 
Electropolymerization is typically conducted by leaving the 
template within the monomer in solution and by applying a 
suitable potential to enable the formation of a thin film on the 
electrode surface. Electropolymerization is thus a very simple 
procedure, enabling the use of different conductive materials of 
different shape/size, and a close control of the polymer thick- 
ness by adjusting the electrochemical conditions under which the 
polymer is formed [33,34]. However, many of the protein struc- 
tures, are typically nm in size, are thus irreversibly entrapped 
inside the polymeric network and only few are at the outer sur- 
face of the newly formed film. The only specific work in this 
context is that of Karimian et al. most recently published [30]. 
The authors report a successful electropolymerized imprinted film 
for troponin, by mixing the cardiac biomarker in the solution 
with o-phenylenediamine, acting as the monomeric unit of the 
film. 
An alternative approach to this procedure, never tested before, 
as far as we know, would  be  first  adsorbing  the proteins to 
the  electrode  surface  (possibly  as  multilayers)  and  to control 
the thickness of the polymer film, to ensure that most of these 
proteins are not irreversibly covered and so can be removed. A 
high density of imprinted cavities is thus expected. Thus, this 
new concept of electropolymerization for imprinting a protein 
cardiac biomarker is here described, using Myo as target pro- 
tein. Myo is a heme protein responsible for the transport of 
oxygen within cardiac and skeletal muscle cells [35,36] that is 
released early in the blood in the course of cardiac muscle dam- 
age. The measurement of Myo levels within the first few hours 
after symptom onset in acute events is crucial to diagnosis of 
cardiac injury. Typical concentrations range from 95 to 472 µg/L 
[35,37–39]. 
Overall, Myo imprinted films (MI) were prepared by elec- 
tropolymerizing o-aminophenol around a protein layer previously 
absorbed to gold. The protein structures located at the outer sur- 
face of the film were removed by protease action. A non-imprinted 
(NI) film was also synthesized in the absence of template to act      
as control. The resulting biosensor was evaluated by several elec- 
trochemical techniques such as CV, EIS and SWV techniques and 
further applied to the analysis of biological  sample. 
 
2. Experimental 
 
2.1. Apparatus 
 
The   electrochemical   measurements   were   conducted   with   
a potentiostat/galvanostat from Metrohm Autolab and a 
PGSTAT302N, equipped with a FRA module and controlled by 
Nova software. The Au-SPEs were purchased to DropSens, and 
have working and counter electrodes made of gold with a reference 
electrode and electrical contacts made of silver. The diameter of   
the working electrode was 4 mm. The SPEs were connected to a 
switch box, also from DropSens (DRP-DSC), allowing their interface 
with  the potentiostat/galvanostat. 
Fourier transform infrared spectroscopy (FTIR) measurements 
were performed using a Thermo Scientific Smart iTR Nicolet iS10, 
coupled to a SAGA smart accessory, also from Thermo Scientific. 
Raman measurements were performed using a Thermo Scientific 
DXR Raman microscope system with a 100 mW 532 nm excitation 
laser, and spectra were made for 5 mW power and 50 µm pinhole 
aperture. 
 
2.2. Reagents 
 
All chemicals were of analytical grade and water was de-ionized 
or ultrapure Milli-Q laboratory grade. Potassium hexacyanoferrate 
III (K3[Fe(CN)6]) and potassium hexacyanoferrate II (K4[Fe(CN)6]) 
trihydrate, and sodium acetate anhydrous, were obtained from 
Riedel-deHaen; bovine serum albumin (BSA), urea, Myo, Troponin 
T (TnT), creatine kinase (CKMB), proteinase K and sodium chloride 
from Fluka; AP 99%, 2-(N-Morpholino)ethanesulphonic acid mono- 
hydrate 98% (MES) from Alfa Aesar; and potassium chloride (KCl) 
from Merck. 
 
2.3. Solutions 
 
Stock solutions for calibration curve of 5.0 10−6 mol/L Myo 
were prepared in MES buffer (1.0 10−2 mol/L, pH 5.0). Less 
concentrated  standards  were  obtained  by  accurate  dilution  
of the previous solution, in the same buffer. Electrochemical 
assays were performed with 5.0   10−3 mol/L K3[Fe(CN)6]     and 
5.0  10−3 mol/L K4[Fe(CN)6], prepared in MES 1.0   10−3 mol/L,   
pH 5.0. The selectivity study used 4.0 µg/mL Myo solutions pre- 
pared  in  buffer  and  solutions  of  possible  interfering       species, 
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TnT (0.22 µg/mL), and CKMB (0.5 µg/mL), prepared in the same 
buffer. 
 
2.4. Electrosynthesis of molecular imprinted and/non-molecular 
imprinted film 
 
Prior to electropolymerization, the Au-SPE electrodes were 
cleaned with ethanol followed by electrochemical cleaning  with 
0.5 M H2SO4 by cycling at potential from 0.2 and 1.2 V, for 15 
cycles, at a scan-rate of 50 mV/s. 
The MI films were produced by covering the working area of 
the Au-SPE with Myo solution, 5.0 10−5mol/L, prepared in acetate 
buffer pH 5, and let it stand there for 15 min on. This solution   was 
then replaced by a drop of 1.0  10−2 mol/L AP, in acetate buffer pH 
5, covering the three-electrodes on the SPE. Polymerization was 
performed by cyclic voltammetry (CV) between    0.2 and 0.8 V, at   
a scan rate of 50 mV/s for 15 cycles. The resulting film was thor- 
oughly washed with deionized water and incubated overnight in 
Proteinase K (500 µg/mL, prepared in PBS buffer, pH 7.4), in the 
dark. The film was finally washed for several times in PBS buffer to 
remove protein fragments and proteinase K, and then rinsed with 
DI water [40]. 
NI materials were produced in parallel in the same way, but 
without the protein incubation step. 
 
2.5. Qualitative characterization of the films 
 
All qualitative analysis was conducted directly on the SPE with- 
out any prior treatment. MI film with Myo present, MI film after 
proteinase K treatment, and NI were analysed by FTIR. A SAGA 
(Sspecular Apertured Gratzing Angle) accessory was employed in 
order to ensure that only tangential infrared beams would be col- 
lected, thus allowing surface analysis. The number of scans was set 
to 256, the resolution to 8, apodization of Happ-Genzel, Mertz Phase 
correction, and a background gain of 8, from 400 to 4000 cm−1 
wavenumber. 
Raman microscopy was carried out using a Thermo Scientific 
DXR Raman microscope, equipped with a 532 nm laser. The average 
signal-to-noise ratio (peak height/RMS noise) was measured using 
standard polystyrene, full-range grating, 15 s measurement time, 
5 mW laser power at sample, and 25 µm slit aperture. 
 
2.6. Binding Isotherm studies 
 
The adsorptions dynamics of MI films before and after electro- 
chemical cleaning with PBS buffer and of NI films was measured 
by SWV assays. This measurement was conducted by adding Myo 
standards ranging from 0.053 to 53.33 µg/mL, prepared in buffer, 
to the electrodes. A 5 min period of incubation was allowed before 
adding the redox probe for subsequent SWV measurements. 
A Langmuir isotherm model (equation 1) was applied to the 
experimental data, where IS was the normalized current-density 
(in mA cm−2), S the concentration of Myo (in µg/mL) and Imax is 
the maximum current density observed (in mA cm−2). The apparent 
dissociation constant (KD) and maximum binding capacity (Bmax) 
were calculated from these data. KD was the protein concentration 
required to provide half of the maximum response produced by the 
device. 
 
 
 
Fig. 1. Schematic representation of the synthetic process of MI. A: Au-SPE; B: Myo 
adsorption on Au-SPE surface; C: electropolymerization of AP; and D: binding site 
formation by template removal with proteinase K. 
 
in MES buffer of pH 5.0 used as redox probe. In CV assays the 
potentials were scanned from 0.2 to +0.8 V, at 50 mV/s; in SWV 
potentials changed from   0.5 to +0.6 V, at a frequency of 50 Hz and 
a step height of 150 mV; and in EIS a standard potential of +0.12 V 
was set, using a sinusoidal potential perturbation of 0.01 V ampli- 
tude and 50 frequency values, logarithmically distributed over a 
frequency range of 0.1–100  kHz. 
Calibration curves were performed by SWV and EIS measure- 
ments for Myoglobin in the range of 0.05–53.3 µg/mL, in MES 
buffer pH5. Selectivity studies were conducted by competitive 
assay between Myo, with a 4.0 µg/mL concentration, and other 
interfering species. The interfering species selected for this pur- 
pose were other cardiac biomarkers that may co-exist with Myo in 
biological fluids: TnT (0.22 µg/mL) and CKMB (0.5 µg/mL). All these 
were prepared in MES buffer pH 5.0. 
Myo determination in samples was performed by SWV mea- 
surements. Myo was prepared in synthetic serum diluted 50 times 
in a range between 0.053 and 53.0 µg/mL. 
 
3. Results and discussion 
 
3.1. Assembly of the responsive polymer 
 
Molecular imprinting was performed by electropolymerization 
of the AP monomer by CV using Myo as a template molecule (Fig. 2). 
The overall process consisted of 3 different stages: (1) Myo adsorp- 
tion on the Au surface of the working electrode; (2) imprinting 
stage by PAP thin film formation on the Au/Myo surface; (3) and 
Myo removal from the PAP film by protease activity (Fig. 1). All 
these stages caused changes in the electron transfer properties of 
receptor surface, and were therefore followed by EIS and CV assays. 
 
3.1.1. Protein adsorption 
As with any other protein, Myo binding to gold is a very complex 
process that may be driven by different forces between the pro- 
tein and the surface, including van-der-Waals, hydrophobic and 
electrostatic interactions. Overall, the adsorption of Myo to    the 
  Imax  
IS = 
1 + (KD/[S]) 
2.7.  Electrochemical assays 
(1) 
solid support is expected to involve transport from the solution 
to the interface, binding to the surface and subsequent relaxation 
via conformational adaptations [41]. Adsorption occurs due to the 
energetically favourable expulsion of solute from solution into 
the interphase between bulk solid and solution phase, along with 
All CV, SWV and EIS measurements were conducted in triplicate 
with 5.0 mmol/L [Fe(CN)6]3− and 5.0 mmol/L [Fe(CN)6]4−, prepared 
the reduction of interfacial energetics resulting from the replac- 
ing of water molecules by adsorbed solute at the solid surface [42]. 
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Fig. 2. Electrochemical control of the subsequent modification steps of the Au-SPE in 5.0 mM [Fe(CN)6]
3− and 5.0 mM [Fe(CN)6]
4−, in MES buffer pH 5, carried out by EIS (A, 
Nyquist plots) and CV (B, cyclic voltammograms) assays for MI/NI. 
 
In addition, this interphase separating bulk solution and surface 
phases may range from few to 100 nm and proteins may appar- 
ently be adsorbed in multilayers at this interphase. 
In the present study, Myo was adsorbed directly to the Au-SPE 
layer, just as indicated in Fig. 1A. This was done by placing a drop of 
Myo, prepared in acetate buffer pH 5, in the working electrode area. 
The incubation period was set to 15 min, at 4 ◦C. The adsorption of 
Myo to gold increases the charge transfer resistance (Rct) signals in 
the EIS spectra. 
3.1.2. Imprinting stage 
The imprinting stage was conducted by electropolymerization 
on the Au-SPE/Myo in an AP solution of pH 5, by consecutive 
potential sweeps in CV mode and the MI device is identified as 
Au-SPE/Myo/PAP. Many electrosynthesized polymers have been 
produced so far in molecular imprint-based materials [43], but PAP 
films exhibit several advantages, including an easy control of the 
polymer thickness within 10-50 nm due to a self-limiting growth 
and an easy regeneration process after use [44–46]. In    addition, 
  
 
 
Fig. 3.  RAMAN spectra for: Au-SPE/Myo/PAP; Au-SPE/Myo; Au-S PE/—/PAP and Au-SPE. 
 
PAP is a permselective polymer with an interfering-free effect from 
some electroactive species present in biological fluids, such ascor- 
bic and uric acid [46]. 
Because it is fundamental to maintain the conformation of the 
protein template upon polymerization, imprinting was established 
in aqueous environment [47]. While hydrophobic interactions 
caused by the exclusion of water are frequently employed with suc- 
cess [47], the dominant forms of template-receptor complexation 
in aqueous protein imprinted materials involve the cooperative 
effect between hydrogen bond formation and hydrophobic interac- 
tion [48]. So, considering that phenoxazine elements are the main 
units of the MI polymeric material [49], hydrophobic interactions 
are expected between the aromatic moieties of the polymer and 
the few hydrophobic residues that may remain on the outer sur- 
face of Myo in aqueous environment. Hydrogen bonding may also 
be established between some of the many polar residues remaining 
on the outer surface of the protein and the O/N atoms of the polymer 
backbone. 
In the course of electropolymerization, the current decreased, 
and when 15 cycles were reached, the current density of the oxi- 
dation peak was much smaller (Fig. 2A, left). No reduction peak 
was observed during electropolymerization, which also confirmed 
the growth of an insulator polymer layer on the Au-SPE electrode. 
Overall, these events confirmed the formation of the PAP film above 
Myo, because it displays non-conductive proprieties [44,50,51]. The 
obtained film was also evident to human eye, as the gold of the SPE 
became dark-brown. Its thickness is expected below 50 nm, due to 
the self-limiting effect, caused by the low polymer film conductivity 
[50]. 
In general, the EIS data obtained with Au-SPE/Myo/PAP was con- 
sistent with the formation of an insulating layer. The typically low 
Rct from gold increased in an expected fashion, reaching values 
more than 60 kQ (Fig. 2B, left). 
The Randles equivalent circuit is normally used to explain the 
electrochemical proprieties of the electrode-solution interfaces 
with the occurrence of Faradaic current diffusion transport [52,53]. 
Nevertheless, Warburg’s impedance part was lacking after the PAP 
film formation. In this case, the equivalent circuit consists of one 
resistor (solution resistance (Rs)) in series with one parallel cir- 
cuit comprised of a resistor (charge transfer resistance (Rct))  and 
a capacitance due to the double layer (Cdl) [52,54,55]. The Nyquist 
plot of a Randles cell consists of a semicircle. At high frequencies 
the impedance of Cdl is very low, and very low frequencies the 
impedance of Cdl becomes high, and thus, the measured impedance 
tends to (Rct + Rs). The diameter of the semicircle is identical to the 
charge-transfer resistance [56]. 
In parallel, a negative control was also employed to create a NI 
film (Au-SPE/PAP). This was done by carrying out the electropoly- 
merization stage over a clean Au-SPE support that did not contact 
Myo (Fig. 2A, right). The CV of such electropolymerization was quite 
similar to that observed in the production of the Au-SPE/Myo/PAP 
film, producing a continuous current decrease in subsequent cycles. 
Compared to the MI film, an additional oxidative peak was evident 
at about 0.5 V. This was probably a result of the absence of the Myo 
layer that acted as a barrier to electrical transfer in the MI film. 
 
3.1.3. Protein removal 
Many strategies for removing protein form imprinted polymers 
have been described to date. These include mostly chemical treat- 
ments that look for protein denaturation and amide bond cleavage 
[57–61]. Most recently, we have proposed the use of enzymes dis- 
playing proteolytic activity capable of cleaving peptide bonds [28]. 
Enzymes are effective and act under mild conditions, thus preven- 
ting significant alterations at the polymeric network. 
The Au-SPE/Myo/PAP film with Myo was therefore incubated 
overnight with Proteinase K 500 µg/mL. Proteinase K is a highly 
active and stable protease with low specificity regarding the pep- 
tide bond environment and high efficiency in cleaving the amide 
bond. The resulting peptide fragments from Myo, along with the 
free enzyme, were after removed by washing thoroughly the sur- 
face. This meant to ensure that the imprinted sites were free for 
Myo rebinding. 
In general, part of the electron transfer ability of the MI film   
was recovered by protein removal (Au-SPE/–/PAP) (Fig. 2B), thus 
indicating that Myo was successfully extracted from the PAP layer. 
This was also confirmed by a similar EIS behaviour between Au- 
SPE/–/PAP and Au-SPE/PAP film after protease action (Fig. 2 C, left). 
Their little difference in Rct is probably confirming the presence of 
the binding sites that facilitated the electron transfer due to their 
smaller distance to the Au layer. CV data also confirmed a close 
behaviour between Au-SPE/PAP and Au-SPE/–/PAP films after pro- 
tease activity (Fig. 2C, right). The oxidation peak observed at 0.5 V 
after protein removal is possibly accounted for by the absence of 
the protein and hence increased film   porosity. 
 
3.2. Qualitative analysis 
 
The chemical profile of the Au-SPE/PAP, Au-SPE/Myo/PAP and 
Au-SPE/–/PAP films was assessed by RAMAN analysis with Confocal 
microscopy (Fig. 3), FTIR (Fig. 4). 
 
3.2.1. Raman spectrometry 
Raman spectra were recorded for Au/SPE/PAP and 
Au/SPE/Myo/PAP surfaces, acting as imprinted and non-imprinted 
surfaces. The typical images obtained are presented in Fig.   3. 
Regarding PAP films, the evidence of peaks at about 1400  
and 1600 cm−1 Raman shift were assigned to quinoid groups   of 
3-aminophenoxazone (APZ) and to the aromatic ring/–C N– in 
quinonimine units, respectively [62–64], from the PAP films. The 
PAP electropolymerization is expected to yield two main products: 
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Fig. 4. FTIR spectra for: Au-SPE/—/PAP; Au-SPE/Myo/PAP and Au-SPE/PAP. 
 
APZ  and  2,21-dihydroxyazobenzene  (DHAB).  APZ  is  cyclic  dimer, 
by the simultaneous N—C and O—C coupling of AP monomer units, 
obtained especially under acidic pH conditions. APZ can be oxidized 
further at the electrode forming the ladder structured polymer [62]. 
DHAB is formed mostly in neutral and basic solutions. 
Spectra of PAP films produced over an SPE that had adsorbed 
Myo showed a significant reduction of the Raman shift at about 
1400 and 1600 cm−1. Possibly this decrease could be linked to the 
presence of Myo on the surface, acting as a barrier to polymer 
growth and reticulation. 
The protein rebinding to the imprinted film was also confirmed 
by Raman spectroscopy. The spectra obtained, Au/SPE/PAP/Myo, 
showed  a  large  band  at  3000 cm−1,  assuming  that  the  plane 
z used for  recording  the  spectra  was  above  the  PAP  film. 
These Raman shifts corresponded to the C–H stretching region 
(2800–3100 cm−1) of various amino acids in proteins [65,66].   Over- 
all,  the  band  near  2940 cm−1  was  attributed  to  aromatic and 
aliphatic amino acids and as well to many other amino acids; a 
band near 3065 cm−1 appears was correlated to aromatic residues; 
while bands near 2880 and 2900 cm−1 corresponded primarily to 
aliphatic amino acids [66]. 
 
3.2.2. Fourier  transformed  infrared spectrometry 
As in Raman assays, the FTIR analysis was conducted directly 
over the SPEs. When this analysis was conducted with an atten- 
uated total reflectance (ATR) accessory, the transmittance data 
was always accounted as major signal the background Au layer 
at the working electrode. So, a Specular Apertured Grazing Angle 
(SAGA) accessory was employed as it enabled the optical beam to 
be focused tangentially on the electrode, thus allowing identifica- 
tion of small changes taking place at the outer surface of this active 
layer. The major drawback of such an approach was the decrease 
in the signal intensity, but this was compensated by an increased 
number of readings. 
The FTIR data obtained with Au-SPE/PAP, Au-SPE/Myo/PAP, and 
Au-SPE/—/PAP electrodes are shown in Fig. 4. The common peaks 
at     1600 cm−1  wavenumber were assigned to the carbonyl   group 
and/or to the characteristic C–C O stretching in 3APZ, resulting 
from the PAP film. The common peaks located at 850 cm−1 were 
assigned to –C–H bending vibration of aromatic ortho-substituted 
aromatic rings, also resulting from PAP. The absence of hydroxyl 
group absorption at 3500 cm−1 could be attributed to a low pro- 
portion of a linear chain polymer structure. 
Overall, the differences within the three spectra are confined to 
two regions that seem to account the presence or removal of Myo 
(Fig. 4). Comparing Au-SPE/PAP with Au-SPE/Myo/PAP, the pres- 
ence of Myo in the later leads to an increased absorption at the 
 
1020 cm−1 and to a decreased absorption at 520 cm−1. The removal 
of Myo from the film Au-SPE/Myo/PAP is detected by the recovery 
of the peak at 520 cm−1 in the FTIR spectra of Au-SPE/—/PAP. The 
presence of some Myo inside the polymer was also evidenced by 
the presence of a small peak at 600 cm−1, which was also present 
in  Au-SPE/Myo/PAP film. 
Overall, the combined information of the FTIR spectra confirm 
the presence of the PAP film over the Au-SPE, the presence of Myo 
at the MI film and its partial removal after protease action. 
 
3.3. Analytical performance of the sensor 
 
SWV and EIS calibration curves were recorded for Au-SPE/—/PAP 
and Au-SPE/PAP electrodes. The calibrations plotted current inten- 
sity (I, in SWV) or Rct (in EIS) against logarithm Myo concentration, 
ranging from 0.05 to 53.3 µg/mL at pH 5 (Fig. 5A and B). In general, 
the presence of Myo in the redox probe concomitantly decreased 
the current of the typical anodic peak at 0.4 V, while increasing 
the resistance on Au-SPE surface. 
Regarding EIS data, the Rct values in the Nyquist plots, increased 
linearly with the increasing of the logarithm of Myo concentration 
after 4.0 µg/mL (Fig. 5B). The slope average was 11.0 kQ/decade log 
[Myo, µg/mL] and the squared correlation coefficients > 0.988. The 
detection limit was 3.53 µg/mL, corresponding to the concentra- 
tion of the cross-section of the two linear parts of the response.      
In the NI sensor, Rct  increase with the increasing of the logarithm  
of Myo concentration after 16.0 µg/mL, but with squared correla- 
tion coefficients > 0.895. These results showed a random behavior, 
showing that the imprinting recognition of Myo was governing the 
electrical response of the MI   electrode. 
In SWV assays, the Au-SPE/—/PAP sensor showed linear 
behaviour down to 2.22 µg/mL, with a slope    0.0247 (       0.003) 
µA/decade log [Myo, µg/mL] and squared correlation coeffi- 
cients > 0.999. The LOD was equal to 0.827 µg/mL. 
The NI sensor, Au-SPE/PAP, displayed linear behavior after 
16 µg/mL, with the slope 0.0142 µA/decade log [Myo, µg/mL] 
and squared correlation coefficients > 0.995. The repeatability of the 
response was good, with standard deviations below than 5%. 
Overall, SWV showed quicker, more sensitive and more selective 
responses to Myo, when compared to EIS assays. So, this electro- 
chemical approach was selected for further studies. 
 
3.4. Binding isotherm 
 
MI creates binding cavities that are expected to be complemen- 
tary to the shape and functionality of the protein. The rebinding 
properties of the MI film after and before electrochemical cleaning 
with PBS were evaluated by the binding equilibrium experiments. 
NI films were also included in this study for comparison purposes. 
The Langmuir isotherm model was used to fit the experimental 
data and the results are shown in Fig. 6. The dissociation constant 
(KD) indicates the necessary Myo concentration to reach one half 
of the maximal velocity for the reaction. This constant is thus a 
combination of the amount of Myo bound to the film and its affin- 
ity. A low KD indicates a large binding affinity, as the reaction will 
approach the maximum velocity (Vmáx) more rapidly, while a high 
Kd indicates that the sensor does not bind as efficiently to Myo, and 
the maximum binding capacity (Bmax) will only be reached if the 
Myo concentration is high enough to saturate the binding sites in 
the film. 
In general, MI showed better features in terms Bmax and KD com- 
paring with NI film. But, the most important information regards 
the need of electrochemical cleaning after protease activity to 
ensure the good affinity of Myo to the Au-SPE/—/PAP film. This 
stage is required to ensure complete removal of unreacted organic 
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Fig. 5. SWV (A) and EIS (B) measurements of MI based Au-SPE biosensor and the corresponding calibration curves (C and D) in 5.0 mM [Fe(CN)6]
3− and 5.0 mM [Fe(CN)6]
4−, 
in MES buffer pH 5, with different concentrations of Myo. Calibration curves of NI based Au-SPE are also included de B and D. 
 
compounds such as traces of monomers on its surface. These com- 
pounds shall promote a barrier, hindering the protein to reach its 
binding sites. The Bmáx and KD values for this were 0.042 mA and 
10 µg/mL, respectively. 
 
 
Fig. 6. Graphical representation of the Langmuir isotherm plot, Imax and KD values, 
for MI (before and after electrochemical surface cleaning) and NI materials. 
3.5. Selectivity study 
 
Selectivity study used SWV measurements of the Au-SPE/—/PAP 
electrodes for solutions of only Myo or  Myo + interfering  species.  
The incubation period  of  the  sensor  with  these  solutions  was  set  
to 10 minutes, to ensure that equilibrium as always reached, even 
when interfering species  were  present.  The  interfering  species  
tested  were  TnT  and  CKMB,  other  cardiac  biomarkers  presents    
in serum. Their concentrations were set  to  their  typical  values  in  
this biological fluid. The % deviation produced by each interfering 
species in pure Myo solutions were 12% for TnT and 8% for CKMB 
respectively. The repeatability of the results accounted standard 
deviations  below 5%. 
Overall, the interference from the above proteins was consid- 
ered negligible, meaning that the MI electrodes, Au-SPE/—/PAP, 
may provide accurate data under the analysis of real samples. 
 
3.6. Sample analysis 
 
Because no access to real samples was possible, synthetic serum 
samples were used to assess the possible application of the device. 
For this purpose, instead of a normal sample application, the 
calibration was made in a background of synthetic serum and com- 
pared to that made previously in buffer. The results obtained are 
presented in Fig. 7. 
In general, spiked serum samples showed good features in terms 
of lower concentration of the linear concentration range, LOD 
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Fig. 7. SWV measurements of MI based Au-SPE biosensor and the corresponding spiked serum samples with different concentrations of Myo. 
 
and slope (0.05 µg/mL, 0.01 µg/mL and     0.0308  µA/decade[Myo, 
µg/mL]) respectively. Comparing with the Myo calibration curve 
in MES buffer pH 5, the LOD is lower accounting a negligible inter- 
ference of the serum matrix. All assays were performed 3 repeated 
measurements. 
 
4. Conclusions 
 
The effective combination of electrochemistry and MI technol- 
ogy in an analytical device provides a promising tool for direct 
electrical detection of proteins. The adsorption of protein over 
the conductive layer promoting the electrosynthesis of the poly- 
meric film seemed to be a successful imprinting approach. This 
new approach may lead to further improvements within the elec- 
tropolymerization imprinted materials, by contributing with a new 
way of forming the imprinted film. 
The present biosensor does not have a better analytical per- 
formance than most of the previous devices employing molecular 
imprinting procedures [67,68,28,25]. However, its response is 
among the range of concentration of clinical significance and the 
device set-up is by far the quicker, the simplest and the cheaper 
process presented so far. Compared to previous immunosensors 
[69,70] it also offers reusability, which is a very useful feature in 
routine applications. 
In general, the biosensor presented here demonstrates simplic- 
ity in designing, short measuring time, reusability, high accuracy, 
low limit of detection and good selectivity. This approach seems a 
successful tool for screening cardiac biomarkers in point of care. 
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